Tissue Engineering Market by Application (Gynecology, Cell Banking & Cord blood, Dental, Urology, Integumentary & Skin, Cardiology, Neurology, Musculoskeletal, Orthopedics, & Spine, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Description

The report covers forecast and analysis for the tissue engineering market on a global and regional level. The study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the tissue engineering market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the tissue engineering market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the tissue engineering market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the tissue engineering market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new indication launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the tissue engineering market on global and regional basis.

The study provides a crucial view on the tissue engineering by segmenting the market based on application and region. All the segments of tissue engineering market have been analyzed based on present and future trends and the market is estimated from 2016 to 2026.

The global demand for tissue engineering market is driven by growing adoption of tissue engineering in regenerative medicine industry, rise in healthcare expenditure, and increasing funding for research and development. However, lack of awareness and high cost may act as restraining factors for the market growth in the coming years. Increasing collaboration and technological advancements are projected to bring new growth avenues for market players during the forecast timeframe.

The tissue engineering market has been divided into application and region. Based on application, global tissue engineering market is segmented into gynecology, cell banking & cord blood, dental, urology, integumentary & skin, cardiology, neurology, musculoskeletal, orthopedics, & spine, and others. Market was dominated by musculoskeletal, orthopedics, & spine segment in 2019 and is projected to retain its dominance over the forecast timeframe. This is because of high number of spine and orthopedic surgeries.

North America held largest revenue share of the global tissue engineering market in 2018. This large share is attributed to high prevalence of lifestyle related disorders, government funding, and presence of state-of-the-art treatment facilities in this region. Europe was second leading regional market in terms of revenue. Availability of developed infrastructure, increasing geriatric population, and growing awareness are major factors that support market growth in this region. Asia Pacific region is projected to be rapidly growing regional market for tissue engineering. Increasing geriatric population base, improvement of healthcare infrastructure, increasing disposable income and healthcare spending, growing awareness are major factors attributing to the swift growth in this region. Moderate growth is projected in Latin America region over the forecast period. Middle East and Africa will witness sluggish growth in the coming years.

Major players in tissue engineering market are Zimmer Biomet Holdings, Inc, Medtronic plc, Allergan plc, ell, Inc., Athersys, Inc, Tissue Regenix Group plc, Organogenesis Holdings Inc, Stryker Corporation, Integra LifeSciences Corporation, RTI Surgical, Inc., Baxter International, Inc., ReproCell, Inc., and Integra LifeSciences Corporation among others.

The report segment of global tissue engineering market as follows:

Global Tissue engineering Market: Application

• Gynecology
• Cell Banking & Cord blood
• Dental
• Urology
• Integumentary & Skin
• Cardiology
• Neurology
• Musculoskeletal, Orthopedics, & Spine
• Others

Global Tissue engineering Market: By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table Of Content

• Chapter 1. Preface
  • 1.1. Report Description and Scope
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology
• Chapter 2. Executive Summary
  • 2.1. Tissue Engineering Market, 2016 - 2026, (USD Million)
  • 2.2. Tissue Engineering Market: Snapshot
• Chapter 3. Global Tissue Engineering Market – Industry Analysis
  • 3.1. Tissue Engineering Market: Market Dynamics
  • 3.2. Market Drivers
    • 3.2.1. Growing adoption of tissue engineering in regenerative medicine industry
    • 3.2.2. Rise in healthcare expenditure
  • 3.3. Restraints
    • 3.3.1. Lack of awareness
    • 3.3.2. High cost
  • 3.4. Opportunity
    • 3.4.1. Increasing cullaboration
    • 3.4.2. Technological advancements
  • 3.5. Porter’s Five Forces Analysis
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market attractiveness analysis by application segment
    • 3.6.2. Market attractiveness analysis by regional segment
• Chapter 4. Global Tissue Engineering Market - Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global tissue engineering market: company market share analysis, 2018
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New indication launches
    • 4.2.3. Agreements, partnerships, cullaborations and joint ventures
    • 4.2.4. Research and development and regional expansion
• Chapter 5. Global Tissue Engineering Market – Application Segment Analysis
  • 5.1. Global tissue engineering market overview: by application
    • 5.1.1. Global tissue engineering market revenue share, by application, 2019 and 2026
  • 5.2. Gyneculogy
    • 5.2.1. Global tissue engineering market by Gyneculogy, 2016 - 2026(USD Million)
  • 5.3. Cell Banking & Cord blood
    • 5.3.1. Global tissue engineering market by Cell Banking & Cord blood, 2016 - 2026(USD Million)
  • 5.4. Dental
    • 5.4.1. Global tissue engineering market by Dental, 2016 - 2026(USD Million)
  • 5.5. Urulogy
    • 5.5.1. Global tissue engineering market by Urulogy, 2016 - 2026(USD Million)
  • 5.6. Integumentary & Skin
    • 5.6.1. Global tissue engineering market by Integumentary & Skin, 2016 - 2026(USD Million)
  • 5.7. Cardiulogy
    • 5.7.1. Global tissue engineering market by Cardiulogy, 2016 - 2026(USD Million)
  • 5.8. Neurulogy
    • 5.8.1. Global tissue engineering market by Neurulogy, 2016 - 2026(USD Million)
  • 5.9. Musculoskeletal, Orthopedics, & Spine
    • 5.9.1. Global tissue engineering market by Musculoskeletal, Orthopedics, & Spine, 2016 - 2026(USD Million)
  • 5.10. Others
    • 5.10.1. Global tissue engineering market by Others, 2016 - 2026(USD Million)
• Chapter 6. Global Tissue Engineering Market - Regional Analysis
  • 6.1. Global tissue engineering market overview: by region
    • 6.1.1. Global tissue engineering market revenue share, by region, 2019 and 2026
  • 6.2. North America
    • 6.2.1. North America tissue engineering market, by country, 2016 - 2026(USD Million)
    • 6.2.2. North America tissue engineering market revenue, by application, 2016 - 2026(USD Million)
    • 6.2.3. The U.S.
      • 6.2.3.1. The U.S. tissue engineering market revenue, by application, 2016 - 2026(USD Million)
    • 6.2.4. Rest of North America
      • 6.2.4.1. Rest of North America tissue engineering market revenue, by application, 2016 - 2026(USD Million)
  • 6.3. Europe
    • 6.3.1. Europe tissue engineering market, by country, 2016 - 2026(USD Million)
    • 6.3.2. Europe tissue engineering market revenue, by application, 2016 - 2026(USD Million)
    • 6.3.3. U.K.
      • 6.3.3.1. U.K. tissue engineering market revenue, by application, 2016 - 2026(USD Million)
    • 6.3.4. France
      • 6.3.4.1. France tissue engineering market revenue, by application, 2016 - 2026(USD Million)
    • 6.3.5. Germany
      • 6.3.5.1. Germany tissue engineering market revenue, by application, 2016 - 2026(USD Million)
    • 6.3.6 Rest of Europe
      • 6.3.6.1. Rest of Europe tissue engineering market revenue, by application, 2016 - 2026(USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific tissue engineering market, by country, 2016 - 2026(USD Million)
    • 6.4.2. Asia Pacific tissue engineering market revenue, by application, 2016 - 2026(USD Million)
    • 6.4.3. China
      • 6.4.3.1. China tissue engineering market revenue, by application, 2016 - 2026(USD Million)
    • 6.4.4. Japan
      • 6.4.4.1. Japan tissue engineering market revenue, by application, 2016 - 2026(USD Million)
    • 6.4.5. India
      • 6.4.5.1. India tissue engineering market revenue, by application, 2016 - 2026(USD Million)
    • 6.4.6. Rest of Asia Pacific
      • 6.4.6.1. Rest of Asia Pacific tissue engineering market revenue, by application, 2016 - 2026(USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America tissue engineering market, by country, 2016 - 2026(USD Million)
    • 6.5.2. Latin America tissue engineering market revenue, by application, 2016 - 2026(USD Million)
    • 6.5.3. Brazil
      • 6.5.3.1. Brazil tissue engineering market revenue, by application, 2016 - 2026(USD Million)
    • 6.5.4. Rest of Latin America
      • 6.5.4.1. Rest of Latin America tissue engineering market revenue, by application, 2016 - 2026(USD Million)
  • 6.6. Middle East & Africa
    • 6.6.1. Middle East & Africa tissue engineering market revenue, by application, 2016 - 2026(USD Million)
• Chapter 7. Company Profiles
  • 7.1. Zimmer Biomet Huldings, Inc
    • 7.1.1. Overview
    • 7.1.2. Financials
    • 7.1.3. Product Portfolio
    • 7.1.4. Business Strategy
    • 7.1.5. Recent Developments
  • 7.2. Medtronic plc
    • 7.2.1. Overview
    • 7.2.2. Financials
    • 7.2.3. Product Portfolio
    • 7.2.4. Business Strategy
    • 7.2.5. Recent Developments
  • 7.3. Allergan plc
    • 7.3.1. Overview
    • 7.3.2. Financials
    • 7.3.3. Product Portfolio
    • 7.3.4. Business Strategy
    • 7.3.5. Recent Developments
  • 7.4. ell, Inc.
    • 7.4.1. Overview
    • 7.4.2. Financials
    • 7.4.3. Product Portfolio
    • 7.4.4. Business Strategy
    • 7.4.5. Recent Developments
  • 7.5. Athersys, Inc
    • 7.5.1. Overview
    • 7.5.2. Financials
    • 7.5.3. Product Portfolio
    • 7.5.4. Business Strategy
    • 7.5.5. Recent Developments
  • 7.6. Tissue Regenix Group plc
    • 7.6.1. Overview
    • 7.6.2. Financials
    • 7.6.3. Product Portfolio
    • 7.6.4. Business Strategy
    • 7.6.5. Recent Developments
  • 7.7. Organogenesis Huldings Inc
    • 7.7.1. Overview
    • 7.7.2. Financials
    • 7.7.3. Product Portfolio
    • 7.7.4. Business Strategy
    • 7.7.5. Recent Developments
  • 7.8. Stryker Corporation
    • 7.8.1. Overview
    • 7.8.2. Financials
    • 7.8.3. Product Portfolio
    • 7.8.4. Business Strategy
    • 7.8.5. Recent Developments
  • 7.9. Integra LifeSciences Corporation
    • 7.9.1. Overview
    • 7.9.2. Financials
    • 7.9.3. Product Portfolio
    • 7.9.4. Business Strategy
    • 7.9.5. Recent Developments
  • 7.10. RTI Surgical, Inc.
    • 7.10.1. Overview
    • 7.10.2. Financials
    • 7.10.3. Product Portfolio
    • 7.10.4. Business Strategy
    • 7.10.5. Recent Developments
  • 7.11. Baxter International, Inc.
    • 7.11.1. Overview
    • 7.11.2. Financials
    • 7.11.3. Product Portfolio
    • 7.11.4. Business Strategy
    • 7.11.5. Recent Developments
  • 7.12. ReproCell, Inc.
    • 7.12.1. Overview
    • 7.12.2. Financials
    • 7.12.3. Product Portfolio
    • 7.12.4. Business Strategy
    • 7.12.5. Recent Developments
  • 7.13. Integra LifeSciences Corporation
    • 7.13.1. Overview
    • 7.13.2. Financials
    • 7.13.3. Product Portfolio
    • 7.13.4. Business Strategy
    • 7.13.5. Recent Developments

Methodology